S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

INDP Indaptus Therapeutics Inc

0.782

-0.057 (-6.79%)

Mar 03 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Indaptus Therapeutics Charts.

Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Indaptus Therapeutics Charts.

Indaptus Therapeutics Inc News

Indaptus Therapeutics’ Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit
Tuesday 25 February 2025 (7 days ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Thursday 13 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Wednesday 12 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 12 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 5 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
Wednesday 5 February 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 31 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Monday 13 January 2025 (2 months ago) • GlobeNewswire Inc.

Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
Wednesday 8 January 2025 (2 months ago) • GlobeNewswire Inc.

Form S-1 - General form for registration of securities under the Securities Act of 1933
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 November 2024 (3 months ago) • Edgar (US Regulatory)

More Indaptus Therapeutics Inc News Articles

Valiant Eagle (PK)

Anavex Life Sciences

Rennova Health (CE)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

Global Developments (PK)

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions